PSORS7
MCID: PSR028
MIFTS: 39

Psoriasis 7 (PSORS7)

Categories: Genetic diseases, Immune diseases, Rare diseases, Skin diseases

Aliases & Classifications for Psoriasis 7

MalaCards integrated aliases for Psoriasis 7:

Name: Psoriasis 7 56 12 73
Psoriasis Susceptibility 7 56 29 13
Psors7 56 12 73
Psoriasis Vulgaris 73 71
Psoriasis 73 71
Psoriasis 7, Susceptibility to 56
Pv 73

Classifications:



External Ids:

Disease Ontology 12 DOID:0111279
OMIM 56 605606
OMIM Phenotypic Series 56 PS177900
MeSH 43 D011565
MedGen 41 C1854124
UMLS 71 C0033860 C0263361

Summaries for Psoriasis 7

UniProtKB/Swiss-Prot : 73 Psoriasis 7: A common, chronic inflammatory disease of the skin with multifactorial etiology. It is characterized by red, scaly plaques usually found on the scalp, elbows and knees. These lesions are caused by abnormal keratinocyte proliferation and infiltration of inflammatory cells into the dermis and epidermis.

MalaCards based summary : Psoriasis 7, also known as psoriasis susceptibility 7, is related to psoriasis and guttate psoriasis, and has symptoms including pruritus, exanthema and psoriasiform rash. An important gene associated with Psoriasis 7 is IL23R (Interleukin 23 Receptor). The drugs Esomeprazole and Dapsone have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and t cells.

Disease Ontology : 12 A psoriasis that has material basis in variation in a region on chromosome 1p that includes IL23R.

More information from OMIM: 605606 PS177900

Related Diseases for Psoriasis 7

Diseases in the Psoriasis family:

Psoriasis 1 Psoriasis 3
Psoriasis 2 Psoriasis 4
Psoriasis 5 Psoriasis 6
Psoriasis 7 Psoriasis 9
Psoriasis 8 Psoriasis 10
Psoriasis 11 Psoriasis 12
Psoriasis 13 Psoriasis 15

Diseases related to Psoriasis 7 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1245, show less)
# Related Disease Score Top Affiliating Genes
1 psoriasis 28.5 PSORS7 IL23R
2 guttate psoriasis 12.7
3 pustular psoriasis 12.7
4 psoriasis 15, pustular 12.6
5 psoriasis 4 12.6
6 psoriasis 3 12.6
7 psoriasis 10 12.6
8 psoriasis 6 12.6
9 psoriasis 5 12.5
10 psoriasis 12 12.5
11 psoriasis 8 12.5
12 psoriatic arthritis 12.5
13 psoriasis 9 12.5
14 psoriasis 15 12.5
15 polycythemia vera 12.4
16 mental retardation and psoriasis 12.3
17 pustulosis palmaris et plantaris 12.3
18 tranebjaerg svejgaard syndrome 12.1
19 psoriatic juvenile idiopathic arthritis 11.9
20 psoriasis 1 11.9
21 impetigo herpetiformis 11.8
22 persistent vegetative state 11.7
23 juvenile rheumatoid arthritis 11.6
24 geographic tongue 11.6
25 pemphigus 11.5
26 parapsoriasis 11.5
27 pemphigus vulgaris, familial 11.5
28 arthritis 11.5
29 pulmonary valve stenosis 11.5
30 spondyloarthropathy 1 11.5
31 vitiligo-associated multiple autoimmune disease susceptibility 1 11.5
32 psoriasis 14, pustular 11.5
33 subacute cutaneous lupus erythematosus 11.4
34 chronic recurrent multifocal osteomyelitis 11.4
35 temporomandibular ankylosis 11.4
36 singleton-merten syndrome 1 11.2
37 rheumatoid factor-negative juvenile idiopathic arthritis 11.2
38 systemic onset juvenile idiopathic arthritis 11.2
39 variegate porphyria 11.2
40 psoriasis 2 11.2
41 psoriasis 11 11.2
42 psoriasis 13 11.2
43 skin disease 11.2
44 nail disorder, nonsyndromic congenital, 1 11.1
45 combined cellular and humoral immune defects with granulomas 11.1
46 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 11.1
47 singleton-merten syndrome 2 11.1
48 primary cutaneous amyloidosis 11.1
49 singleton-merten syndrome 11.1
50 dermatitis 10.9
51 dermatitis, atopic 10.9
52 autoimmune disease 10.8
53 polycystic kidney disease 10.7
54 inflammatory bowel disease 10.7
55 arthropathy 10.6
56 crohn's disease 10.6
57 inflammatory spondylopathy 10.6
58 spondylitis 10.6
59 lipid metabolism disorder 10.6
60 vitiligo-associated multiple autoimmune disease susceptibility 6 10.6
61 alopecia 10.6
62 polycythemia 10.6
63 cytokine deficiency 10.5
64 lichen planus 10.5
65 exanthem 10.5
66 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.5
67 contact dermatitis 10.5
68 essential thrombocythemia 10.5
69 rheumatoid arthritis 10.5
70 hpa i recognition polymorphism, beta-globin-related 10.5
71 neurofibromatosis, type ii 10.5
72 body mass index quantitative trait locus 1 10.5
73 nail disease 10.5
74 fatty liver disease 10.4
75 nasopharyngitis 10.4
76 uveitis 10.4
77 urticaria 10.4
78 ulcerative colitis 10.4
79 non-alcoholic fatty liver disease 10.4
80 nail disorder, nonsyndromic congenital, 10 10.4
81 myelofibrosis 10.4
82 hepatitis c 10.4
83 seborrheic dermatitis 10.4
84 alopecia areata 10.4
85 atherosclerosis susceptibility 10.4
86 acrodermatitis 10.4
87 mycosis fungoides 10.4
88 neurodermatitis 10.4
89 basal cell carcinoma 10.4
90 proteasome-associated autoinflammatory syndrome 1 10.4
91 ichthyosis 10.4
92 pik3ca-related overgrowth syndrome 10.4
93 crohn's colitis 10.3
94 tonsillitis 10.3
95 enthesopathy 10.3
96 allergic contact dermatitis 10.3
97 pityriasis rubra pilaris 10.3
98 malaria 10.3
99 splenomegaly 10.3
100 posttransplant acute limbic encephalitis 10.3
101 body mass index quantitative trait locus 11 10.3
102 immune deficiency disease 10.3
103 body mass index quantitative trait locus 9 10.3
104 body mass index quantitative trait locus 8 10.3
105 body mass index quantitative trait locus 4 10.3
106 body mass index quantitative trait locus 10 10.3
107 body mass index quantitative trait locus 7 10.3
108 body mass index quantitative trait locus 12 10.3
109 body mass index quantitative trait locus 14 10.3
110 body mass index quantitative trait locus 18 10.3
111 body mass index quantitative trait locus 19 10.3
112 body mass index quantitative trait locus 20 10.3
113 skin atrophy 10.3
114 dermatophytosis 10.3
115 systemic lupus erythematosus 10.3
116 hidradenitis 10.3
117 sarcoidosis 1 10.3
118 squamous cell carcinoma 10.3
119 hidradenitis suppurativa 10.3
120 leprosy 3 10.3
121 lymphopenia 10.3
122 hansen's disease 10.3
123 multiple sclerosis 10.3
124 hepatitis c virus 10.3
125 vasculitis 10.3
126 depression 10.3
127 alcohol dependence 10.3
128 alcohol use disorder 10.3
129 diabetes mellitus 10.3
130 lymphoma 10.3
131 diarrhea 10.3
132 candidiasis 10.3
133 47,xyy 10.3
134 spondyloarthropathy 10.2
135 gout 10.2
136 hyperuricemia 10.2
137 kidney disease 10.2
138 periodontitis 10.2
139 nevus, epidermal 10.2
140 melanoma 10.2
141 papilloma 10.2
142 hypereosinophilic syndrome 10.2
143 acute generalized exanthematous pustulosis 10.2
144 leukemia, acute myeloid 10.2
145 helix syndrome 10.2
146 atrial fibrillation 10.2
147 allergic hypersensitivity disease 10.2
148 hypertriglyceridemia, familial 10.2
149 celiac disease 1 10.2
150 sleep apnea 10.2
151 alexithymia 10.2
152 hepatitis b 10.2
153 ige responsiveness, atopic 10.2
154 impetigo 10.2
155 amyloidosis 10.2
156 myocardial infarction 10.2
157 colitis 10.2
158 pharyngitis 10.2
159 systemic scleroderma 10.2
160 folliculitis 10.2
161 thyroiditis 10.2
162 rosacea 10.2
163 arteries, anomalies of 10.2
164 hyperlipoproteinemia, type iii 10.2
165 fissured tongue 10.2
166 coronary artery anomaly 10.2
167 syphilis 10.2
168 pyoderma 10.2
169 chronic kidney disease 10.2
170 chickenpox 10.2
171 hair whorl 10.2
172 myeloid leukemia 10.2
173 kaposi sarcoma 10.2
174 dowling-degos disease 1 10.2
175 sexual disorder 10.2
176 rheumatic disease 10.2
177 scleroderma, familial progressive 10.2
178 pulmonary disease, chronic obstructive 10.2
179 impotence 10.2
180 glomerulonephritis 10.2
181 congestive heart failure 10.2
182 cerebrovascular disease 10.2
183 coronary heart disease 1 10.2
184 cutaneous t cell lymphoma 10.2
185 hypothyroidism 10.2
186 viral hepatitis 10.2
187 iga glomerulonephritis 10.2
188 scabies 10.2
189 mastitis 10.1
190 pertussis 10.1
191 thrombocytosis 10.1
192 heritable pulmonary arterial hypertension 10.1
193 hypercholesterolemia, familial, 1 10.1
194 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 10.1
195 erythema multiforme 10.1
196 porokeratosis 10.1
197 pneumonia 10.1
198 inflammatory linear verrucous epidermal nevus 10.1
199 methotrexate toxicity 10.1
200 fibrosis of extraocular muscles, congenital, 1 10.1
201 graft-versus-host disease 10.1
202 hypoparathyroidism 10.1
203 hepatitis 10.1
204 acquired immunodeficiency syndrome 10.1
205 pyoderma gangrenosum 10.1
206 iridocyclitis 10.1
207 telangiectasis 10.1
208 opisthorchiasis 10.1
209 demyelinating disease 10.1
210 cellulitis 10.1
211 sleep disorder 10.1
212 progressive multifocal leukoencephalopathy 10.1
213 pemphigus foliaceus 10.1
214 sarcoma 10.1
215 cheilitis 10.1
216 hyperostosis 10.1
217 purpura 10.1
218 spindle cell sarcoma 10.1
219 pityriasis rosea 10.1
220 osteoporosis 10.1
221 human immunodeficiency virus type 1 10.1
222 bone mineral density quantitative trait locus 8 10.1
223 bone mineral density quantitative trait locus 15 10.1
224 peripheral vascular disease 10.1
225 glossitis 10.1
226 idiopathic interstitial pneumonia 10.1
227 pulmonary fibrosis 10.1
228 discoid lupus erythematosus 10.1
229 epidermodysplasia verruciformis 1 10.1
230 thrombosis 10.1
231 myeloproliferative neoplasm 10.1
232 pigmented villonodular synovitis 10.1
233 synovitis 10.1
234 skin carcinoma 10.1
235 villonodular synovitis 10.1
236 rapidly involuting congenital hemangioma 10.1
237 hashimoto thyroiditis 10.1
238 asthma 10.1
239 osteomyelitis 10.1
240 squamous cell papilloma 10.1
241 lung disease 10.1
242 herpes simplex 10.1
243 lentigines 10.1
244 tinea pedis 10.1
245 end stage renal failure 10.1
246 subcorneal pustular dermatosis 10.1
247 measles 10.1
248 ichthyosis vulgaris 10.0
249 lung cancer 10.0
250 helicobacter pylori infection 10.0
251 mycobacterium tuberculosis 1 10.0
252 deficiency anemia 10.0
253 non-alcoholic steatohepatitis 10.0
254 pancytopenia 10.0
255 epidermolysis bullosa 10.0
256 irritant dermatitis 10.0
257 mood disorder 10.0
258 hyperglycemia 10.0
259 connective tissue disease 10.0
260 dermatitis herpetiformis 10.0
261 tenosynovitis 10.0
262 bowen's disease 10.0
263 exfoliative dermatitis 10.0
264 colorectal cancer 10.0
265 renal cell carcinoma, nonpapillary 10.0
266 neutrophil migration 10.0
267 pulmonary fibrosis, idiopathic 10.0
268 down syndrome 10.0
269 lymphoma, hodgkin, classic 10.0
270 dermatitis herpetiformis, familial 10.0
271 homocysteinemia 10.0
272 lymphoma, non-hodgkin, familial 10.0
273 kawasaki disease 10.0
274 microcephaly, epilepsy, and diabetes syndrome 10.0
275 paronychia 10.0
276 norwegian scabies 10.0
277 capillary leak syndrome 10.0
278 hyperinsulinism 10.0
279 ankylosis 10.0
280 bone inflammation disease 10.0
281 secondary syphilis 10.0
282 epidermolysis bullosa acquisita 10.0
283 spongiotic dermatitis 10.0
284 osteoarthritis 10.0
285 localized scleroderma 10.0
286 hypoglycemia 10.0
287 stevens-johnson syndrome/toxic epidermal necrolysis 10.0
288 keratitis, hereditary 10.0
289 triiodothyronine receptor auxiliary protein 10.0
290 varicose veins 10.0
291 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
292 insulin-like growth factor i 10.0
293 cutaneous lupus erythematosus 10.0
294 dermatomyositis 10.0
295 portal hypertension 10.0
296 esophageal varix 10.0
297 rabies 10.0
298 cardiac tamponade 10.0
299 plasmodium vivax malaria 10.0
300 keratosis 10.0
301 liver disease 10.0
302 endophthalmitis 10.0
303 liver cirrhosis 10.0
304 bullous skin disease 10.0
305 bullous pemphigoid 10.0
306 herpes zoster 10.0
307 actinic keratosis 10.0
308 48,xyyy 10.0
309 candida glabrata 10.0
310 benign chronic pemphigus 10.0
311 allergic rhinitis 10.0
312 membranous nephropathy 10.0
313 tetanus 10.0
314 heart disease 10.0
315 pulmonary sarcoidosis 10.0
316 polyneuropathy 10.0
317 oral candidiasis 10.0
318 gonadal dysgenesis 10.0
319 cholecystitis 10.0
320 acute kidney failure 10.0
321 turner syndrome 10.0
322 rhinitis 10.0
323 reactive arthritis 10.0
324 parasitic helminthiasis infectious disease 10.0
325 cholangitis 10.0
326 palmoplantar keratoderma, punctate type ii 10.0
327 small cell cancer of the lung 10.0
328 hypervitaminosis a 10.0
329 periodontitis, chronic 10.0
330 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
331 diffuse alopecia areata 10.0
332 nephrotic syndrome 10.0
333 personality disorder 10.0
334 relapsing-remitting multiple sclerosis 10.0
335 conjunctivitis 10.0
336 stomatitis 10.0
337 punctate porokeratosis 10.0
338 atrial standstill 1 9.9
339 hepatocellular carcinoma 9.9
340 lichen sclerosus et atrophicus 9.9
341 migraine with or without aura 1 9.9
342 porokeratosis 1, multiple types 9.9
343 schizophrenia 9.9
344 alopecia universalis congenita 9.9
345 familial mediterranean fever 9.9
346 myeloma, multiple 9.9
347 taqi polymorphism 9.9
348 leukemia, chronic myeloid 9.9
349 angina pectoris 9.9
350 restless legs syndrome 9.9
351 mucositis 9.9
352 osteomalacia 9.9
353 diphtheria 9.9
354 tinea corporis 9.9
355 cholestasis 9.9
356 avoidant personality disorder 9.9
357 mental depression 9.9
358 histoplasmosis 9.9
359 autoimmune hepatitis 9.9
360 relapsing polychondritis 9.9
361 interstitial lung disease 9.9
362 vaccinia 9.9
363 mesangial proliferative glomerulonephritis 9.9
364 human immunodeficiency virus infectious disease 9.9
365 scarlet fever 9.9
366 molluscum contagiosum 9.9
367 hard palate cancer 9.9
368 erythrokeratoderma ''en cocardes'' 9.9
369 pityriasis lichenoides 9.9
370 back pain 9.9
371 breast cancer 9.9
372 hypertension, essential 9.9
373 gallbladder disease 1 9.9
374 kala-azar 1 9.9
375 severe cutaneous adverse reaction 9.9
376 leukemia, acute lymphoblastic 3 9.9
377 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.9
378 bone resorption disease 9.9
379 hypopyon 9.9
380 common cold 9.9
381 glucose intolerance 9.9
382 erysipelas 9.9
383 alcoholic hepatitis 9.9
384 dilated cardiomyopathy 9.9
385 balanitis 9.9
386 porphyria 9.9
387 iritis 9.9
388 disease of mental health 9.9
389 clear cell acanthoma 9.9
390 acanthoma 9.9
391 hypogonadism 9.9
392 kidney cancer 9.9
393 pulmonary tuberculosis 9.9
394 scalp dermatosis 9.9
395 keratoacanthoma 9.9
396 ischemia 9.9
397 palmoplantar keratosis 9.9
398 granuloma annulare 9.9
399 proliferative glomerulonephritis 9.9
400 hypogonadotropism 9.9
401 gastrointestinal system disease 9.9
402 hyperthyroidism 9.9
403 cataract 9.9
404 influenza 9.9
405 eating disorder 9.9
406 leishmaniasis 9.9
407 eczema herpeticum 9.9
408 blepharitis 9.9
409 fasciitis 9.9
410 acute graft versus host disease 9.9
411 frontal fibrosing alopecia 9.9
412 pityriasis lichenoides chronica 9.9
413 pseudoainhum 9.9
414 spondylarthropathy 9.9
415 chronic actinic dermatitis 9.9
416 erythema multiforme major 9.9
417 coloboma of macula 9.8
418 li-fraumeni syndrome 9.8
419 neurofibromatosis, type iv, of riccardi 9.8
420 ovarian cancer 9.8
421 phosphoglucomutase 4 9.8
422 polykaryocytosis inducer 9.8
423 thrombophilia due to thrombin defect 9.8
424 thyroid cancer, nonmedullary, 2 9.8
425 anencephaly 9.8
426 ocular motor apraxia 9.8
427 fragile x syndrome 9.8
428 androgen insensitivity, partial 9.8
429 prostatic hyperplasia, benign 9.8
430 adenomyosis 9.8
431 eukaryotic translation elongation factor 1 alpha-1-like 14 9.8
432 late-onset retinal degeneration 9.8
433 epilepsy, partial, with pericentral spikes 9.8
434 spastic paraplegia, ataxia, and mental retardation 9.8
435 anxiety 9.8
436 li-fraumeni syndrome 2 9.8
437 major affective disorder 8 9.8
438 major affective disorder 9 9.8
439 myelodysplastic syndrome 9.8
440 pulmonary hypertension, primary, 2 9.8
441 chromosome 15q11.2 deletion syndrome 9.8
442 speech and communication disorders 9.8
443 atrioventricular block 9.8
444 autism spectrum disorder 9.8
445 corneal disease 9.8
446 bacterial infectious disease 9.8
447 primary polycythemia 9.8
448 bullous keratopathy 9.8
449 prostatic hypertrophy 9.8
450 chlamydia 9.8
451 adult respiratory distress syndrome 9.8
452 hemopericardium 9.8
453 pericardial effusion 9.8
454 hemosiderosis 9.8
455 neutropenia 9.8
456 leukemia 9.8
457 plasmodium falciparum malaria 9.8
458 toxic shock syndrome 9.8
459 frozen shoulder 9.8
460 thrombocytopenia 9.8
461 heart septal defect 9.8
462 vascular disease 9.8
463 pericarditis 9.8
464 status epilepticus 9.8
465 atrial heart septal defect 9.8
466 basilar artery insufficiency 9.8
467 transient cerebral ischemia 9.8
468 keratopathy 9.8
469 motor neuron disease 9.8
470 gastroenteritis 9.8
471 iron metabolism disease 9.8
472 splenic infarction 9.8
473 hemangioma 9.8
474 acquired polycythemia 9.8
475 prostatic adenoma 9.8
476 bursitis 9.8
477 bipolar disorder 9.8
478 thyroid gland follicular carcinoma 9.8
479 heart valve disease 9.8
480 filamentary keratitis 9.8
481 eye disease 9.8
482 peripheral nervous system disease 9.8
483 severe combined immunodeficiency 9.8
484 combined t cell and b cell immunodeficiency 9.8
485 b-cell lymphoma 9.8
486 neuroblastoma 9.8
487 corneal ulcer 9.8
488 neuropathy 9.8
489 lupus erythematosus 9.8
490 pityriasis versicolor 9.8
491 myotonic dystrophy 9.8
492 sickle cell disease 9.8
493 pulmonary vein stenosis 9.8
494 stenotrophomonas maltophilia infection 9.8
495 anoxia 9.8
496 spinal cord injury 9.8
497 rare hereditary hemochromatosis 9.8
498 pemphigus vegetans 9.8
499 overgrowth syndrome 9.8
500 thyroid carcinoma 9.8
501 acroosteolysis 9.8
502 annular erythema 9.8
503 alopecia, androgenetic, 1 9.8
504 myasthenia gravis 9.8
505 stroke, ischemic 9.8
506 resting heart rate, variation in 9.8
507 fatty liver disease, nonalcoholic 1 9.8
508 leptin deficiency or dysfunction 9.8
509 hydrops, lactic acidosis, and sideroblastic anemia 9.8
510 androgenic alopecia 9.8
511 pollen allergy 9.8
512 spinal disease 9.8
513 autosomal recessive congenital ichthyosis 9.8
514 lymphoproliferative syndrome 9.8
515 sensorineural hearing loss 9.8
516 endocarditis 9.8
517 polycystic ovary syndrome 9.8
518 guillain-barre syndrome 9.8
519 cardiovascular system disease 9.8
520 keratoconjunctivitis sicca 9.8
521 focal segmental glomerulosclerosis 9.8
522 megaloblastic anemia 9.8
523 skin sarcoidosis 9.8
524 generalized anxiety disorder 9.8
525 retinal vein occlusion 9.8
526 arteriosclerosis 9.8
527 acute pancreatitis 9.8
528 adenocarcinoma 9.8
529 gingivitis 9.8
530 necrobiosis lipoidica 9.8
531 aortic aneurysm 9.8
532 hypertrichosis 9.8
533 hair disease 9.8
534 uremia 9.8
535 poliomyelitis 9.8
536 pancreatitis 9.8
537 chronic inflammatory demyelinating polyradiculoneuropathy 9.8
538 demyelinating polyneuropathy 9.8
539 bronchitis 9.8
540 diffuse idiopathic skeletal hyperostosis 9.8
541 monoclonal gammopathy of uncertain significance 9.8
542 peptic ulcer disease 9.8
543 placenta disease 9.8
544 septic arthritis 9.8
545 subacute delirium 9.8
546 keratoconjunctivitis 9.8
547 pulmonary embolism 9.8
548 chronic graft versus host disease 9.8
549 autonomic dysfunction 9.8
550 cytomegalovirus infection 9.8
551 paresthesia 9.8
552 lymphedema 9.8
553 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.8
554 apnea, obstructive sleep 9.8
555 porphyria cutanea tarda 9.8
556 keratosis, seborrheic 9.8
557 temporal arteritis 9.8
558 anemia, autoimmune hemolytic 9.8
559 diabetes mellitus, insulin-dependent 9.8
560 myeloperoxidase deficiency 9.8
561 netherton syndrome 9.8
562 pituitary adenoma, prolactin-secreting 9.8
563 branchiootic syndrome 1 9.8
564 huntington disease-like 3 9.8
565 cone-rod synaptic disorder, congenital nonprogressive 9.8
566 lung cancer susceptibility 3 9.8
567 alpha-1-antitrypsin deficiency 9.8
568 hypophosphatemia 9.8
569 hyperphosphatemia 9.8
570 extrapulmonary tuberculosis 9.8
571 bone disease 9.8
572 mumps 9.8
573 lymphocytic leukemia 9.8
574 pre-eclampsia 9.8
575 fanconi syndrome 9.8
576 myiasis 9.8
577 anogenital venereal wart 9.8
578 pulmonary edema 9.8
579 mitral valve insufficiency 9.8
580 conn's syndrome 9.8
581 panuveitis 9.8
582 optic neuritis 9.8
583 common variable immunodeficiency 9.8
584 secondary hyperparathyroidism 9.8
585 acute kidney tubular necrosis 9.8
586 dementia 9.8
587 hyperparathyroidism 9.8
588 eclampsia 9.8
589 childhood type dermatomyositis 9.8
590 oligospermia 9.8
591 panniculitis 9.8
592 thrombocytopenia due to platelet alloimmunization 9.8
593 neuritis 9.8
594 calcinosis 9.8
595 drug-induced hepatitis 9.8
596 central retinal vein occlusion 9.8
597 agammaglobulinemia 9.8
598 hairy cell leukemia 9.8
599 cryoglobulinemia 9.8
600 substance abuse 9.8
601 lipomatosis 9.8
602 mammary paget's disease 9.8
603 verrucous carcinoma 9.8
604 gastritis 9.8
605 pseudohypoparathyroidism 9.8
606 myopathy 9.8
607 hemolytic anemia 9.8
608 fibromyalgia 9.8
609 inverted follicular keratosis 9.8
610 t-cell leukemia 9.8
611 in situ carcinoma 9.8
612 skin melanoma 9.8
613 meningitis 9.8
614 yellow fever 9.8
615 irritable bowel syndrome 9.8
616 periostitis 9.8
617 hemophilia 9.8
618 keloid disorder 9.8
619 central serous chorioretinopathy 9.8
620 granulocytopenia 9.8
621 homologous wasting disease 9.8
622 leukoplakia 9.8
623 polymyositis 9.8
624 superficial spreading melanoma 9.8
625 raynaud phenomenon 9.8
626 familial pityriasis rubra pilaris 9.8
627 aneurysm 9.8
628 chronic pain 9.8
629 headache 9.8
630 pituitary tumors 9.8
631 inflammatory myopathy with abundant macrophages 9.8
632 anti-p200 pemphigoid 9.8
633 epidermal disease 9.8
634 autoinflammatory syndrome 9.8
635 pustulosis of palm and sole 9.8
636 aortic aneurysm, familial abdominal, 1 9.7
637 acanthosis nigricans 9.7
638 arthritis, sacroiliac 9.7
639 gastroesophageal reflux 9.7
640 epidermolytic hyperkeratosis 9.7
641 cardiac arrhythmia 9.7
642 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.7
643 factor viii deficiency 9.7
644 lymphoma, mucosa-associated lymphoid type 9.7
645 geographic and fissured tongue 9.7
646 leukemia, chronic lymphocytic 9.7
647 otitis media 9.7
648 prostate cancer 9.7
649 pulmonary hypertension, primary, 1 9.7
650 thrombocytopenic purpura, autoimmune 9.7
651 thyroid cancer, nonmedullary, 1 9.7
652 tobacco addiction 9.7
653 arterial calcification, generalized, of infancy, 1 9.7
654 hemochromatosis, type 1 9.7
655 xeroderma pigmentosum, variant type 9.7
656 hemophilia a 9.7
657 aging 9.7
658 macular degeneration, age-related, 1 9.7
659 dermatitis, atopic, 2 9.7
660 huntington disease-like 2 9.7
661 major depressive disorder 9.7
662 aplastic anemia 9.7
663 smoking as a quantitative trait locus 3 9.7
664 acute promyelocytic leukemia 9.7
665 microvascular complications of diabetes 3 9.7
666 microvascular complications of diabetes 4 9.7
667 microvascular complications of diabetes 6 9.7
668 microvascular complications of diabetes 7 9.7
669 osteomyelitis, sterile multifocal, with periostitis and pustulosis 9.7
670 aspergillosis 9.7
671 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.7
672 aortic valve disease 2 9.7
673 chronic ulcer of skin 9.7
674 tendinitis 9.7
675 autoimmune uveitis 9.7
676 cryptogenic organizing pneumonia 9.7
677 adult t-cell leukemia 9.7
678 diffuse large b-cell lymphoma 9.7
679 marginal zone b-cell lymphoma 9.7
680 secondary progressive multiple sclerosis 9.7
681 follicular lymphoma 9.7
682 immunoglobulin alpha deficiency 9.7
683 ductal carcinoma in situ 9.7
684 lymphocytic colitis 9.7
685 angular cheilitis 9.7
686 zika fever 9.7
687 latex allergy 9.7
688 venous insufficiency 9.7
689 dry eye syndrome 9.7
690 osteonecrosis 9.7
691 cholelithiasis 9.7
692 charcot-marie-tooth disease 9.7
693 interstitial nephritis 9.7
694 renal hypertension 9.7
695 thrombotic thrombocytopenic purpura 9.7
696 filariasis 9.7
697 hand, foot and mouth disease 9.7
698 lepromatous leprosy 9.7
699 tooth disease 9.7
700 lipoid nephrosis 9.7
701 discitis 9.7
702 respiratory failure 9.7
703 keratomalacia 9.7
704 epidural abscess 9.7
705 tinea cruris 9.7
706 pulmonary alveolar proteinosis 9.7
707 chagas disease 9.7
708 goiter 9.7
709 vogt-koyanagi-harada disease 9.7
710 posterior uveitis 9.7
711 balanoposthitis 9.7
712 acquired hyperkeratosis 9.7
713 tinea manuum 9.7
714 urethritis 9.7
715 scleritis 9.7
716 alcoholic liver cirrhosis 9.7
717 autoimmune polyendocrine syndrome 9.7
718 prostatitis 9.7
719 chromoblastomycosis 9.7
720 dermatomycosis 9.7
721 conjunctival squamous cell carcinoma 9.7
722 optic nerve disease 9.7
723 telogen effluvium 9.7
724 exostosis 9.7
725 chronic mucocutaneous candidiasis 9.7
726 hereditary multiple exostoses 9.7
727 constipation 9.7
728 dental caries 9.7
729 vaginitis 9.7
730 vulvovaginitis 9.7
731 psychotic disorder 9.7
732 transitional cell carcinoma 9.7
733 bruxism 9.7
734 immune system disease 9.7
735 membranoproliferative glomerulonephritis 9.7
736 gingival overgrowth 9.7
737 fibrosarcoma 9.7
738 mixed connective tissue disease 9.7
739 mastocytosis 9.7
740 thrombophlebitis 9.7
741 vulvitis 9.7
742 thyroid gland papillary carcinoma 9.7
743 mouth disease 9.7
744 primary syphilis 9.7
745 coronary stenosis 9.7
746 superficial basal cell carcinoma 9.7
747 cutaneous fibrous histiocytoma 9.7
748 macular retinal edema 9.7
749 neurotic disorder 9.7
750 elephantiasis 9.7
751 thyroid gland disease 9.7
752 adjustment disorder 9.7
753 aortitis 9.7
754 aortic valve insufficiency 9.7
755 eosinophilic pneumonia 9.7
756 adenoma 9.7
757 monocytic leukemia 9.7
758 chronic fatigue syndrome 9.7
759 multiple carboxylase deficiency 9.7
760 intermediate coronary syndrome 9.7
761 chorioretinitis 9.7
762 erythematosquamous dermatosis 9.7
763 visceral leishmaniasis 9.7
764 splenic tuberculosis 9.7
765 lipid storage disease 9.7
766 plantar fasciitis 9.7
767 aphthous stomatitis 9.7
768 hereditary multiple osteochondromas 9.7
769 hypertrophic cardiomyopathy 9.7
770 acquired hemophilia 9.7
771 al amyloidosis 9.7
772 allergic encephalomyelitis 9.7
773 amyloidosis aa 9.7
774 carcinoid syndrome 9.7
775 carcinoma showing thymus-like differentiation 9.7
776 ichthyosis, acquired 9.7
777 linear lichen planus 9.7
778 mycobacterium marinum 9.7
779 oral lichen planus 9.7
780 prurigo nodularis 9.7
781 pyogenic granuloma 9.7
782 streptococcal group a invasive disease 9.7
783 sudden sensorineural hearing loss 9.7
784 b-cell non-hodgkin lymphoma 9.7
785 systemic autoimmune disease 9.7
786 autosomal dominant epidermolytic ichthyosis 9.7
787 avascular necrosis 9.7
788 iga pemphigus 9.7
789 acute liver failure 9.7
790 hyperpigmentation of the skin 9.7
791 glomerular disease 9.7
792 primary adrenal insufficiency 9.7
793 cutaneous myiasis 9.7
794 acrokeratosis verruciformis 9.5
795 ainhum 9.5
796 basal cell nevus syndrome 9.5
797 behcet syndrome 9.5
798 bladder cancer 9.5
799 cardiac conduction defect 9.5
800 leukocyte adhesion deficiency, type i 9.5
801 charcot-marie-tooth disease, demyelinating, type 1a 9.5
802 cleidocranial dysplasia 9.5
803 cryoglobulinemia, familial mixed 9.5
804 darier-white disease 9.5
805 diabetes mellitus, noninsulin-dependent 9.5
806 dupuytren contracture 9.5
807 dyschromatosis symmetrica hereditaria 9.5
808 epidermoid cysts 9.5
809 pilomatrixoma 9.5
810 fanconi renotubular syndrome 1 9.5
811 felty syndrome 9.5
812 periodic fever, familial, autosomal dominant 9.5
813 attention deficit-hyperactivity disorder 9.5
814 hypercalciuria, absorptive, 2 9.5
815 palmoplantar keratoderma, epidermolytic 9.5
816 immunoglobulin e concentration, serum 9.5
817 keloid formation 9.5
818 leiomyoma, uterine 9.5
819 leukemia, acute monocytic 9.5
820 lipomatosis, multiple 9.5
821 mastocytosis, cutaneous 9.5
822 melkersson-rosenthal syndrome 9.5
823 metaphyseal chondrodysplasia, schmid type 9.5
824 myelopathy, htlv-1-associated 9.5
825 myositis 9.5
826 neuropathy, hereditary, with liability to pressure palsies 9.5
827 noonan syndrome 1 9.5
828 paget disease, extramammary 9.5
829 actinic prurigo 9.5
830 pulmonary hemosiderosis 9.5
831 neural tube defects 9.5
832 spondyloarthropathy 2 9.5
833 strabismus 9.5
834 chromosome 2q35 duplication syndrome 9.5
835 syringomyelia, noncommunicating isolated 9.5
836 thrombophilia due to activated protein c resistance 9.5
837 digeorge syndrome 9.5
838 trigeminal neuralgia 9.5
839 urate oxidase, pseudogene 9.5
840 whim syndrome 9.5
841 wilms tumor 1 9.5
842 alkaptonuria 9.5
843 chondrodysplasia punctata syndrome 9.5
844 chondrosarcoma 9.5
845 pituitary adenoma 4, acth-secreting 9.5
846 eosinophilic fasciitis 9.5
847 goodpasture syndrome 9.5
848 hutterite cerebroosteonephrodysplasia syndrome 9.5
849 hypoadrenocorticism, familial 9.5
850 acetylation, slow 9.5
851 moyamoya disease 1 9.5
852 holocarboxylase synthetase deficiency 9.5
853 myxedema 9.5
854 pulmonic stenosis 9.5
855 retinitis pigmentosa 9.5
856 short stature-obesity syndrome 9.5
857 sjogren syndrome 9.5
858 tardive dyskinesia 9.5
859 restrictive dermopathy, lethal 9.5
860 tinea imbricata 9.5
861 werner syndrome 9.5
862 wilson disease 9.5
863 hypomelanosis of ito 9.5
864 chondrodysplasia punctata 2, x-linked dominant 9.5
865 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 9.5
866 ichthyosis, x-linked 9.5
867 incontinentia pigmenti 9.5
868 glaucoma-related pigment dispersion syndrome 9.5
869 wilms tumor 5 9.5
870 autoimmune lymphoproliferative syndrome 9.5
871 malignant atrophic papulosis 9.5
872 ossification of the posterior longitudinal ligament of spine 9.5
873 acromelic frontonasal dysostosis 9.5
874 sickle cell anemia 9.5
875 reflex sympathetic dystrophy 9.5
876 brooke-spiegler syndrome 9.5
877 systemic lupus erythematosus 3 9.5
878 abdominal obesity-metabolic syndrome 1 9.5
879 dermatitis, atopic, 3 9.5
880 dermatitis, atopic, 4 9.5
881 birdshot chorioretinopathy 9.5
882 dermatitis, atopic, 5 9.5
883 alveolar soft part sarcoma 9.5
884 nasopharyngeal carcinoma 9.5
885 creatinine clearance quantitative trait locus 9.5
886 dermatofibrosarcoma protuberans 9.5
887 hypertensive nephropathy 9.5
888 neutrophilic dermatosis, acute febrile 9.5
889 autoimmune disease 3 9.5
890 legionnaire disease 9.5
891 granulomatosis with polyangiitis 9.5
892 lung cancer susceptibility 1 9.5
893 chilblain lupus 1 9.5
894 intraocular pressure quantitative trait locus 9.5
895 celiac disease 6 9.5
896 peripapillary atrophy, beta type 9.5
897 lipoprotein glomerulopathy 9.5
898 diabetes mellitus, ketosis-prone 9.5
899 myd88 deficiency 9.5
900 inflammatory bowel disease 17 9.5
901 microvascular complications of diabetes 5 9.5
902 trichotillomania 9.5
903 dermatitis, atopic, 9 9.5
904 ectodermal dysplasia-syndactyly syndrome 2 9.5
905 gastric cancer 9.5
906 okt4 epitope deficiency 9.5
907 cfhr5 deficiency 9.5
908 human herpesvirus 8 9.5
909 erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige 9.5
910 bardet-biedl syndrome 7 9.5
911 thrombocytopenia 5 9.5
912 brown syndrome 9.5
913 autoinflammatory syndrome, familial, behcet-like 9.5
914 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.5
915 epidermodysplasia verruciformis 2 9.5
916 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.5
917 tendinopathy 9.5
918 pulmonary hypertension 9.5
919 chikungunya 9.5
920 hemophagocytic lymphohistiocytosis 9.5
921 epstein-barr virus hepatitis 9.5
922 variola major 9.5
923 mantle cell lymphoma 9.5
924 metabolic acidosis 9.5
925 peripheral artery disease 9.5
926 renal fibrosis 9.5
927 oral squamous cell carcinoma 9.5
928 mucosal melanoma 9.5
929 infective endocarditis 9.5
930 withdrawal disorder 9.5
931 interleukin-7 receptor alpha deficiency 9.5
932 aphasia 9.5
933 pharynx cancer 9.5
934 microscopic colitis 9.5
935 gastroduodenal crohn's disease 9.5
936 basal ganglia calcification 9.5
937 xanthinuria 9.5
938 dowling-degos disease 9.5
939 cardiac arrest 9.5
940 anal fistula 9.5
941 ectopic pregnancy 9.5
942 acrodermatitis chronica atrophicans 9.5
943 punctate palmoplantar keratoderma 9.5
944 penicillin allergy 9.5
945 recessive dystrophic epidermolysis bullosa 9.5
946 physical disorder 9.5
947 cryptococcal meningitis 9.5
948 cutaneous candidiasis 9.5
949 nodal marginal zone lymphoma 9.5
950 x-linked chondrodysplasia punctata 2 9.5
951 igg4-related disease 9.5
952 hyper ige syndrome 9.5
953 hypogonadotropic hypogonadism 9.5
954 angioimmunoblastic t-cell lymphoma 9.5
955 castleman disease 9.5
956 asymptomatic neurosyphilis 9.5
957 nodular malignant melanoma 9.5
958 pigmentation disease 9.5
959 keratoconus 9.5
960 xerophthalmia 9.5
961 thymus lymphoma 9.5
962 neuroretinitis 9.5
963 pleomorphic lipoma 9.5
964 borderline leprosy 9.5
965 parotitis 9.5
966 legionellosis 9.5
967 meningoencephalitis 9.5
968 microphthalmia 9.5
969 giardiasis 9.5
970 methemoglobinemia 9.5
971 gastric ulcer 9.5
972 kuhnt-junius degeneration 9.5
973 dissociative disorder 9.5
974 strongyloidiasis 9.5
975 pseudopterygium 9.5
976 pinguecula 9.5
977 depersonalization disorder 9.5
978 henoch-schoenlein purpura 9.5
979 t cell deficiency 9.5
980 disseminated intravascular coagulation 9.5
981 social phobia 9.5
982 arteriovenous malformation 9.5
983 pneumocystosis 9.5
984 gingival recession 9.5
985 autonomic nervous system disease 9.5
986 suppurative otitis media 9.5
987 hypertensive heart disease 9.5
988 corneal abscess 9.5
989 retinal vasculitis 9.5
990 hyperandrogenism 9.5
991 cicatricial pemphigoid 9.5
992 palindromic rheumatism 9.5
993 nephrosclerosis 9.5
994 familial hyperlipidemia 9.5
995 portal vein thrombosis 9.5
996 gestational diabetes 9.5
997 lyme disease 9.5
998 iron deficiency anemia 9.5
999 cryptococcosis 9.5
1000 dysthymic disorder 9.5
1001 aseptic meningitis 9.5
1002 primary biliary cirrhosis 9.5
1003 paranoid schizophrenia 9.5
1004 graves' disease 9.5
1005 hepatitis a 9.5
1006 acute leukemia 9.5
1007 paracoccidioidomycosis 9.5
1008 blastomycosis 9.5
1009 locked-in syndrome 9.5
1010 leiomyoma 9.5
1011 quadriplegia 9.5
1012 hypochondriasis 9.5
1013 alcoholic cardiomyopathy 9.5
1014 conduct disorder 9.5
1015 carotid stenosis 9.5
1016 tinea unguium 9.5
1017 branch retinal artery occlusion 9.5
1018 central retinal artery occlusion 9.5
1019 crescentic glomerulonephritis 9.5
1020 acute cystitis 9.5
1021 cutaneous porphyria 9.5
1022 hairy tongue 9.5
1023 posterior scleritis 9.5
1024 sapho syndrome 9.5
1025 plantar wart 9.5
1026 familial hypercholesterolemia 9.5
1027 somatization disorder 9.5
1028 algoneurodystrophy 9.5
1029 folic acid deficiency anemia 9.5
1030 toxic labyrinthitis 9.5
1031 azoospermia 9.5
1032 chronic purulent otitis media 9.5
1033 adult-onset still's disease 9.5
1034 sclerosing cholangitis 9.5
1035 cholinergic urticaria 9.5
1036 sporotrichosis 9.5
1037 labyrinthitis 9.5
1038 ectropion 9.5
1039 diffuse scleroderma 9.5
1040 rheumatic fever 9.5
1041 lymphadenitis 9.5
1042 neovascular glaucoma 9.5
1043 peritoneum cancer 9.5
1044 epilepsy 9.5
1045 leiomyosarcoma 9.5
1046 rectum cancer 9.5
1047 vulvar disease 9.5
1048 spondylosis 9.5
1049 nocardiosis 9.5
1050 acromegaly 9.5
1051 thrombophilia 9.5
1052 blepharoconjunctivitis 9.5
1053 retinal vascular disease 9.5
1054 splenic abscess 9.5
1055 hematologic cancer 9.5
1056 opiate dependence 9.5
1057 cervicitis 9.5
1058 tic disorder 9.5
1059 bronchiolitis obliterans 9.5
1060 nonspecific interstitial pneumonia 9.5
1061 bronchiolitis 9.5
1062 carbohydrate metabolic disorder 9.5
1063 breast ductal carcinoma 9.5
1064 early myoclonic encephalopathy 9.5
1065 skin squamous cell carcinoma 9.5
1066 tropical spastic paraparesis 9.5
1067 myelitis 9.5
1068 syringomyelia 9.5
1069 laryngitis 9.5
1070 retinitis 9.5
1071 anal canal adenocarcinoma 9.5
1072 vaginal discharge 9.5
1073 pleural empyema 9.5
1074 photoallergic dermatitis 9.5
1075 pituitary adenoma 9.5
1076 placental insufficiency 9.5
1077 insulinoma 9.5
1078 merkel cell carcinoma 9.5
1079 eosinophilic gastroenteritis 9.5
1080 nodular basal cell carcinoma 9.5
1081 polyradiculoneuropathy 9.5
1082 tinea capitis 9.5
1083 acneiform dermatitis 9.5
1084 neuromuscular disease 9.5
1085 hepatitis e 9.5
1086 clear cell renal cell carcinoma 9.5
1087 hypotrichosis 9.5
1088 mesenchymal chondrosarcoma 9.5
1089 extraskeletal mesenchymal chondrosarcoma 9.5
1090 multiple chemical sensitivity 9.5
1091 mongolian spot 9.5
1092 somatoform disorder 9.5
1093 angiokeratoma 9.5
1094 sebaceous adenocarcinoma 9.5
1095 epidermolysis bullosa dystrophica 9.5
1096 hydrarthrosis 9.5
1097 intestinal disease 9.5
1098 paget's disease of bone 9.5
1099 lung oat cell carcinoma 9.5
1100 schizoaffective disorder 9.5
1101 dystonia 9.5
1102 t-cell adult acute lymphocytic leukemia 9.5
1103 tricuspid valve prolapse 9.5
1104 spinal stenosis 9.5
1105 lung lymphoma 9.5
1106 hepatoblastoma 9.5
1107 acth-secreting pituitary adenoma 9.5
1108 subacute thyroiditis 9.5
1109 diverticulitis 9.5
1110 muscular atrophy 9.5
1111 delusional disorder 9.5
1112 osteochondrosis 9.5
1113 myocarditis 9.5
1114 peritonitis 9.5
1115 appendicitis 9.5
1116 extrinsic allergic alveolitis 9.5
1117 cyclothymic disorder 9.5
1118 pellagra 9.5
1119 retinal artery occlusion 9.5
1120 collagen disease 9.5
1121 sezary's disease 9.5
1122 duodenitis 9.5
1123 gastroduodenitis 9.5
1124 substance-induced psychosis 9.5
1125 tongue cancer 9.5
1126 vascular dementia 9.5
1127 smallpox 9.5
1128 rubella 9.5
1129 cervix uteri carcinoma in situ 9.5
1130 ritter's disease 9.5
1131 macroglobulinemia 9.5
1132 cutaneous leishmaniasis 9.5
1133 ocular hypertension 9.5
1134 mechanical strabismus 9.5
1135 orbital plasma cell granuloma 9.5
1136 exophthalmos 9.5
1137 epiglottitis 9.5
1138 acute myocardial infarction 9.5
1139 intracranial hypertension 9.5
1140 otitis externa 9.5
1141 bronchiectasis 9.5
1142 necrotizing fasciitis 9.5
1143 neurofibroma 9.5
1144 biliary tract disease 9.5
1145 hypersensitivity vasculitis 9.5
1146 polyarteritis nodosa 9.5
1147 miliary tuberculosis 9.5
1148 toxoplasmosis 9.5
1149 albinism 9.5
1150 bap1 tumor predisposition syndrome 9.5
1151 c3 glomerulopathy 9.5
1152 cleidocranial dysplasia spectrum disorder 9.5
1153 47, xxy 9.5
1154 acquired hemophilia a 9.5
1155 acute articular rheumatism 9.5
1156 acute monoblastic leukemia 9.5
1157 alopecia totalis 9.5
1158 aminoaciduria 9.5
1159 cataract-glaucoma 9.5
1160 cervical intraepithelial neoplasia 9.5
1161 demodicidosis 9.5
1162 drug reaction with eosinophilia and systemic symptoms 9.5
1163 erythroplakia 9.5
1164 exercise-induced anaphylaxis 9.5
1165 familial episodic pain syndrome 9.5
1166 familial glucocorticoid deficiency 9.5
1167 fibromatosis 9.5
1168 gigantism 9.5
1169 glucagonoma 9.5
1170 grover's disease 9.5
1171 hemorrhagic proctocolitis 9.5
1172 htlv-1 associated myelopathy/tropical spastic paraparesis 9.5
1173 keratosis follicularis spinulosa decalvans 9.5
1174 kikuchi disease 9.5
1175 lewis-sumner syndrome 9.5
1176 lichen planus pemphigoides 9.5
1177 lichen planus pigmentosus 9.5
1178 linear iga disease 9.5
1179 malakoplakia 9.5
1180 mercury poisoning 9.5
1181 mondor disease 9.5
1182 mycobacterium abscessus 9.5
1183 mycobacterium fortuitum 9.5
1184 neurosyphilis 9.5
1185 oncogenic osteomalacia 9.5
1186 papular mucinosis 9.5
1187 periodontal ehlers-danlos syndrome 9.5
1188 pityriasis lichenoides et varioliformis acuta 9.5
1189 precocious puberty 9.5
1190 pseudo-turner syndrome 9.5
1191 retroperitoneal fibrosis 9.5
1192 scleromyxedema 9.5
1193 secondary adrenal insufficiency 9.5
1194 spastic paraparesis 9.5
1195 t-cell/histiocyte rich large b cell lymphoma 9.5
1196 transverse myelitis 9.5
1197 childhood myocerebrohepatopathy spectrum 9.5
1198 hereditary xanthinuria 9.5
1199 atrial fibrillation and stroke 9.5
1200 dysphagia 9.5
1201 foot drop 9.5
1202 hereditary neuropathies 9.5
1203 hypotonia 9.5
1204 porokeratotic eccrine ostial and dermal duct nevus 9.5
1205 chronic cutaneous lupus erythematosus 9.5
1206 rare rheumatologic disease 9.5
1207 acute transverse myelitis 9.5
1208 cerebrofacial arteriovenous metameric syndrome 9.5
1209 nevus of ota 9.5
1210 pulmonary arterial hypertension associated with another disease 9.5
1211 herpetiform pemphigus 9.5
1212 primary cutaneous lymphoma 9.5
1213 isoniazid toxicity 9.5
1214 idiopathic nephrotic syndrome 9.5
1215 phalangeal microgeodic syndrome 9.5
1216 epstein-barr virus-associated malignant lymphoproliferative disorder 9.5
1217 myospherulosis 9.5
1218 acquired methemoglobinemia 9.5
1219 cutaneous pseudolymphoma 9.5
1220 chronic enteropathy associated with slco2a1 gene 9.5
1221 polyarticular juvenile idiopathic arthritis 9.5
1222 deep dermatophytosis 9.5
1223 zinc-responsive necrolytic acral erythema 9.5
1224 epidermolytic nevus 9.5
1225 granulomatous mastitis 9.5
1226 argyria 9.5
1227 disorder of purine metabolism 9.5
1228 rare genetic skin disease 9.5
1229 lichen amyloidosis 9.5
1230 serotonin syndrome 9.5
1231 superficial pemphigus 9.5
1232 obsolete: methotrexate poisoning 9.5
1233 renal dysplasia 9.5
1234 discrete papular lichen myxedematosus 9.5
1235 premature aging 9.5
1236 pemphigus erythematosus 9.5
1237 inherited epidermolysis bullosa 9.5
1238 hereditary palmoplantar keratoderma 9.5
1239 acrokeratoderma 9.5
1240 hepatosplenic t-cell lymphoma 9.5
1241 cardiogenic shock 9.5
1242 type ii mixed cryoglobulinemia 9.5
1243 uremic pruritus 9.5
1244 refractory anemia 9.5
1245 streptococcal toxic-shock syndrome 9.5

Graphical network of the top 20 diseases related to Psoriasis 7:



Diseases related to Psoriasis 7

Symptoms & Phenotypes for Psoriasis 7

Clinical features from OMIM:

605606

UMLS symptoms related to Psoriasis 7:


pruritus, exanthema, psoriasiform rash

Drugs & Therapeutics for Psoriasis 7

Drugs for Psoriasis 7 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 458, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Esomeprazole Approved, Investigational Phase 4 161973-10-0, 161796-78-7, 119141-88-7 4594 9568614
2
Dapsone Approved, Investigational Phase 4 80-08-0 2955
3
Clobetasol Approved, Experimental, Investigational Phase 4 25122-46-7, 25122-41-2 32798 5311051
4
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
5
carbamide peroxide Approved Phase 4 124-43-6
6
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
7
Clocortolone Approved Phase 4 34097-16-0, 4828-27-7 5282493 5311052
8
Sodium citrate Approved, Investigational Phase 4 68-04-2
9
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
10 Orange Approved Phase 4
11 Strawberry Approved Phase 4
12 Artichoke Approved Phase 4
13
Sorafenib Approved, Investigational Phase 4 284461-73-0 216239 406563
14
Abatacept Approved Phase 4 332348-12-6 10237
15
Tofacitinib Approved, Investigational Phase 4 477600-75-2
16
Adalimumab Approved Phase 4 331731-18-1 16219006
17
Zinc Approved, Investigational Phase 4 7440-66-6 32051
18
Desoximetasone Approved Phase 4 382-67-2 5311067
19
Certolizumab pegol Approved Phase 4 428863-50-7
20
Mercaptopurine Approved Phase 4 50-44-2 667490
21
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
22
Sotalol Approved Phase 4 3930-20-9, 959-24-0 5253
23
Metformin Approved Phase 4 657-24-9 4091 14219
24
Ustekinumab Approved, Investigational Phase 4 815610-63-0
25 Ixekizumab Approved, Investigational Phase 4 1143503-69-8
26 Vedolizumab Approved Phase 4 943609-66-3
27
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
28
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
29
Salicylic acid Approved, Investigational, Vet_approved Phase 4 69-72-7 338
30
Capsaicin Approved Phase 4 404-86-4 1548943
31
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 22737-96-8, 11103-57-4, 68-26-8 9904001 445354
32
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
33
Glycine Approved, Nutraceutical, Vet_approved Phase 4 56-40-6 750
34
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 134070 5280453
35
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
36 Retinol palmitate Phase 4
37 retinol Phase 4
38 Antiparasitic Agents Phase 4
39 Antimalarials Phase 4
40 Antiprotozoal Agents Phase 4
41 Chlorpheniramine, phenylpropanolamine drug combination Phase 4
42 Omega 3 Fatty Acid Phase 4
43 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
44 Tin Fluorides Phase 4
45
Chondroitin Phase 4 9007-27-6 53477707
46 Halobetasol Phase 4
47 Clocortolone pivalate Phase 4
48 Olive Phase 4
49 Citrate Phase 4
50 Anticoagulants Phase 4
51 Natriuretic Agents Phase 4
52 diuretics Phase 4
53 Lidocaine, Prilocaine Drug Combination Phase 4
54 Neurotransmitter Agents Phase 4
55 Cyclosporins Phase 4
56 Protein Kinase Inhibitors Phase 4
57 Pyrithione zinc Phase 4
58 Autonomic Agents Phase 4
59 Adrenergic Agents Phase 4
60 Antipyretics Phase 4
61 Cyclooxygenase Inhibitors Phase 4
62 Sympatholytics Phase 4
63 Anti-Arrhythmia Agents Phase 4
64 Adrenergic Antagonists Phase 4
65 Adrenergic beta-Antagonists Phase 4
66 Sodium Channel Blockers Phase 4
67 Diuretics, Potassium Sparing Phase 4
68 Mesalamine Phase 4 89-57-6
69 Fibrinolytic Agents Phase 4
70 Platelet Aggregation Inhibitors Phase 4
71 Trace Elements Phase 4
72 Vitamins Phase 4
73 Respiratory System Agents Phase 4
74 Micronutrients Phase 4
75 Nutrients Phase 4
76 Anti-Asthmatic Agents Phase 4
77 Betamethasone-17,21-dipropionate Phase 4
78 Betamethasone Valerate Phase 4 2152-44-5
79 Calcium, Dietary Phase 4
80 Calcipotriene Phase 4
81 Betamethasone sodium phosphate Phase 4
82 Betamethasone benzoate Phase 4
83 Emollients Phase 4
84 Antifungal Agents Phase 4
85 Vaccines Phase 4
86 Cayenne Phase 4
87 Antipruritics Phase 4
88
Methoxsalen Approved Phase 3 298-81-7 4114
89
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
90
Hydrocortisone acetate Approved, Vet_approved Phase 3 50-03-3
91
Hydrocortisone Approved, Vet_approved Phase 3 50-23-7 5754
92
Ethanol Approved Phase 3 64-17-5 702